Cargando…
Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study
OBJECTIVE: To evaluate the clinical and microbiological efficacy and safety of three doses of 3 g fosfomycin tromethamine administered orally to treat lower urinary tract infections. DESIGN AND PARTICIPANTS: This prospective, uncontrolled, open-label study was conducted in 12 medical centres in Chin...
Autores principales: | Qiao, Lu-Dong, Zheng, Bo, Chen, Shan, Yang, Yong, Zhang, Kai, Guo, Hong-Feng, Yang, Bo, Niu, Yuan-Jie, Wang, Yi, Shi, Ben-Kang, Yang, Wei-Min, Zhao, Xiao-Kun, Gao, Xiao-Feng, Chen, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855495/ https://www.ncbi.nlm.nih.gov/pubmed/24309172 http://dx.doi.org/10.1136/bmjopen-2013-004157 |
Ejemplares similares
-
Evaluation of perioperative prophylaxis with fosfomycin tromethamine in ureteroscopic stone removal: an investigator-driven prospective, multicenter, randomized, controlled study
por: Qiao, Lu-Dong, et al.
Publicado: (2017) -
Plasma and Urine Pharmacokinetics of Oral Fosfomycin Tromethamine in Dogs
por: Jariyapamornkoon, Nattha, et al.
Publicado: (2023) -
Fosfomycin tromethamine. Antibiotic of choice in the female patient: A multicenter study
por: Khawaja, Abdul Rouf, et al.
Publicado: (2015) -
Current status and progression of lower urinary tract symptoms in Chinese male patients: the protocol and rationale for a nationwide, hospital-based, prospective, multicentre study
por: Song, Qi-Xiang, et al.
Publicado: (2019) -
Catheter-Associated Urinary Tract Infection (CAUTI)
por: Rubi, Hodam, et al.
Publicado: (2022)